Good Governance for Medicines (GGM)
The GGM programme was launched in 2004 with the goal of contributing to health systems strengthening and preventing corruption by promoting good governance in the pharmaceutical sector.
Specifically the programme aims to:
- To raise awareness on the impact of corruption in the pharmaceutical sector and bring this to the national health policy agenda
- To increase transparency and accountability in medicine regulatory and supply management systems
- To promote individual and institutional integrity in the pharmaceutical sector
- To institutionalize good governance in pharmaceutical systems by building national capacity and leadership.
The concept underlying the GGM approach is that by supporting policy-makers and national officials to understand where the strengths and weaknesses lie in national pharmaceutical systems, appropriate interventions can be developed and applied.